NYSE - Delayed Quote USD
CONMED Corporation (CNMD)
57.08
-0.67
(-1.16%)
At close: May 9 at 4:00:02 PM EDT
55.06
-2.02
(-3.54%)
After hours: May 9 at 6:22:52 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 35,321 | 5 |
| Sales | 4,257 | 2 |
| Net Shares Purchased (Sold) | 31,064 | 7 |
| Total Insider Shares Held | 160.89k | -- |
| % Net Shares Purchased (Sold) | 23.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FARKAS CHARLES M Director | Sale at price 56.94 per share. | Direct | 227,768 | May 5, 2025 |
| GARNER TODD W. Chief Financial Officer | Stock Award(Grant) at price 57.37 per share. | Direct | 21,284 | Mar 31, 2025 |
| SHAGORY PETER K MBA Officer | Conversion of Exercise of derivative security at price 55.42 per share. | Direct | 249,390 | Mar 14, 2025 |
| LALOMIA BRENT Officer | -- | Direct | -- | Mar 7, 2025 |
| GLAZE RICHARD Chief Technology Officer | Sale at price 65.35 per share. | Direct | 16,796 | Feb 11, 2025 |
| GLAZE RICHARD Chief Technology Officer | -- | Direct | -- | Nov 20, 2024 |
| HARTMAN CURT R Chief Executive Officer | Conversion of Exercise of derivative security at price 51.30 per share. | Direct | 1,539,000 | Nov 7, 2024 |
| FARKAS CHARLES M Director | Conversion of Exercise of derivative security at price 39.64 per share. | Direct | 39,640 | Sep 5, 2024 |
| CLIFFORD EDWARD A Officer | -- | Direct | -- | Aug 1, 2024 |
| PETERS STANLEY W III Officer | Sale at price 71.82 per share. | Direct | 287,280 | Jun 14, 2024 |
| PETERS STANLEY W III Officer | Conversion of Exercise of derivative security at price 41.93 per share. | Direct | 167,720 | Jun 14, 2024 |
| SCHWARZENTRAUB BARBARA J Director | -- | Direct | -- | May 31, 2024 |
| COUNCIL LAVERNE H. Director | -- | Direct | -- | May 31, 2024 |
| CONCANNON BRIAN P Director | -- | Direct | -- | May 31, 2024 |
| BRONSON DAVID M Director | -- | Direct | -- | May 31, 2024 |
| ARONSON MARTHA GOLDBERG Director | -- | Direct | -- | May 31, 2024 |
| LANDE JEROME J. Director | -- | Direct | -- | May 31, 2024 |
| FARKAS CHARLES M Director | -- | Direct | -- | May 31, 2024 |
| WORKMAN JOHN LEE Director | -- | Direct | -- | May 31, 2024 |
| BRONSON DAVID M Director | Purchase at price 72.09 per share. | Direct | 97,322 | May 13, 2024 |
| SCHWARZENTRAUB BARBARA J Director | Purchase at price 69.26 per share. | Indirect | 99,873 | May 8, 2024 |
| ARONSON MARTHA GOLDBERG Director | Purchase at price 70.98 per share. | Indirect | 141,960 | May 6, 2024 |
| BEYER PATRICK J Chief Operating Officer | Purchase at price 68.30 per share. | Direct | 204,900 | Apr 30, 2024 |
| COHEN HEATHER L Officer | Stock Award(Grant) at price 76.08 per share. | Direct | 17,270 | Mar 28, 2024 |
| GARNER TODD W. Chief Financial Officer | Stock Award(Grant) at price 76.08 per share. | Direct | 17,270 | Mar 28, 2024 |
| COHEN HEATHER L Officer | Conversion of Exercise of derivative security at price 59.96 - 78.76 per share. | Direct | 3,617,900 | Mar 8, 2024 |
| LALOMIA BRENT Officer | -- | Direct | -- | Mar 7, 2024 |
| PETERS STANLEY W III Officer | Sale at price 109.93 per share. | Direct | 252,833 | Dec 4, 2023 |
| PETERS STANLEY W III Officer | Conversion of Exercise of derivative security at price 41.93 per share. | Direct | 96,439 | Dec 4, 2023 |
| PETERS STANLEY W III Officer | Sale at price 102.40 per share. | Direct | 122,874 | Nov 7, 2023 |
| PETERS STANLEY W III Officer | Conversion of Exercise of derivative security at price 41.93 per share. | Direct | 50,316 | Nov 7, 2023 |
| PETERS STANLEY W III Officer | Sale at price 107.31 per share. | Direct | 214,629 | Sep 13, 2023 |
| PETERS STANLEY W III Officer | Conversion of Exercise of derivative security at price 41.93 per share. | Direct | 83,860 | Sep 13, 2023 |
| GARNER TODD W. Chief Financial Officer | Sale at price 112.00 per share. | Direct | 151,760 | Aug 16, 2023 |
| COHEN HEATHER L Officer | Stock Award(Grant) at price 129.10 per share. | Direct | 2,066 | Jun 30, 2023 |
| LALOMIA BRENT Officer | -- | Direct | -- | Jun 16, 2023 |
| HARTMAN CURT R. Chief Executive Officer | Sale at price 136.00 per share. | Direct | 136,000 | Jun 15, 2023 |
| SHAGORY PETER K MBA Officer | Conversion of Exercise of derivative security at price 55.42 per share. | Direct | 249,390 | Jun 9, 2023 |
| FERRELL JOHN D Officer | Sale at price 131.81 per share. | Direct | 224,077 | Jun 8, 2023 |
| PETERS STANLEY W III Officer | Sale at price 131.14 per share. | Direct | 655,676 | Jun 8, 2023 |
| FERRELL JOHN D Officer | Conversion of Exercise of derivative security at price 41.93 per share. | Direct | 71,281 | Jun 8, 2023 |
| PETERS STANLEY W III Officer | Conversion of Exercise of derivative security at price 41.93 per share. | Direct | 209,650 | Jun 8, 2023 |
| CONCANNON BRIAN P Director | Sale at price 129.01 per share. | Direct | 104,756 | Jun 7, 2023 |
| SCHWARZENTRAUB BARBARA J Director | -- | Direct | -- | Jun 1, 2023 |
| COUNCIL LAVERNE H. Director | -- | Direct | -- | Jun 1, 2023 |
| CONCANNON BRIAN P Director | -- | Direct | -- | Jun 1, 2023 |
| BRONSON DAVID M Director | -- | Direct | -- | Jun 1, 2023 |
| ARONSON MARTHA GOLDBERG Director | -- | Direct | -- | Jun 1, 2023 |
| LANDE JEROME J. Director | -- | Direct | -- | Jun 1, 2023 |
| FARKAS CHARLES M Director | -- | Direct | -- | Jun 1, 2023 |
Related Tickers
OFIX Orthofix Medical Inc.
12.11
-1.62%
SRDX Surmodics, Inc.
26.76
-1.65%
AVNS Avanos Medical, Inc.
12.65
+0.56%
ENOV Enovis Corporation
33.05
-0.09%
HAE Haemonetics Corporation
68.19
+0.26%
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%
ITGR Integer Holdings Corporation
118.44
-0.90%
ZIMV ZimVie Inc.
8.76
-4.68%
IART Integra LifeSciences Holdings Corporation
12.25
-4.97%
CBLL CeriBell, Inc.
15.97
-6.61%